Product Code: ETC5243129 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Belgium Animal Vaccines Market may undergo a gradual slowdown in growth rates between 2025 and 2029. Although the growth rate starts strong at 6.11% in 2025, it steadily loses momentum, ending at 2.14% by 2029.
The Animal Vaccines market in Belgium is projected to grow at a growing growth rate of 5.69% by 2027, highlighting the country's increasing focus on advanced technologies within the Europe region, where Germany holds the dominant position, followed closely by United Kingdom, France, Italy and Russia, shaping overall regional demand.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Animal Vaccines Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Animal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Animal Vaccines Market - Industry Life Cycle |
3.4 Belgium Animal Vaccines Market - Porter's Five Forces |
3.5 Belgium Animal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Belgium Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.7 Belgium Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Belgium Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Belgium Animal Vaccines Market Trends |
6 Belgium Animal Vaccines Market Segmentations |
6.1 Belgium Animal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Belgium Animal Vaccines Market Revenues & Volume, By Attenuated Live Vaccines, 2021-2031F |
6.1.3 Belgium Animal Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021-2031F |
6.1.4 Belgium Animal Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021-2031F |
6.1.5 Belgium Animal Vaccines Market Revenues & Volume, By DNA Vaccines, 2021-2031F |
6.1.6 Belgium Animal Vaccines Market Revenues & Volume, By Recombinant Vaccines, 2021-2031F |
6.2 Belgium Animal Vaccines Market, By Animal Type |
6.2.1 Overview and Analysis |
6.2.2 Belgium Animal Vaccines Market Revenues & Volume, By Livestock, 2021-2031F |
6.2.3 Belgium Animal Vaccines Market Revenues & Volume, By Companion, 2021-2031F |
6.3 Belgium Animal Vaccines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Belgium Animal Vaccines Market Revenues & Volume, By Subcutaneous, 2021-2031F |
6.3.3 Belgium Animal Vaccines Market Revenues & Volume, By Intramuscular, 2021-2031F |
6.3.4 Belgium Animal Vaccines Market Revenues & Volume, By Intranasal, 2021-2031F |
7 Belgium Animal Vaccines Market Import-Export Trade Statistics |
7.1 Belgium Animal Vaccines Market Export to Major Countries |
7.2 Belgium Animal Vaccines Market Imports from Major Countries |
8 Belgium Animal Vaccines Market Key Performance Indicators |
9 Belgium Animal Vaccines Market - Opportunity Assessment |
9.1 Belgium Animal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Belgium Animal Vaccines Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.3 Belgium Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Belgium Animal Vaccines Market - Competitive Landscape |
10.1 Belgium Animal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Belgium Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |